Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue engineering: current state and prospects.

U A Stock1, J P Vacanti

  • 1Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Center for Innovative Minimally Invasive Therapy, 55 Fruit Street, Boston, Massachusetts 02114, USA. jvacanti@partners.org

Annual Review of Medicine
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Huge thrombus attached to implantable cardioverter defibrillator line resulting in severe tricuspid inflow obstruction.

European heart journal. Cardiovascular Imaging·2019
Same author

Long-term radiation exposure in patients undergoing EVAR: Reflecting clinical day-to-day practice to assess realistic radiation burden.

Clinical hemorheology and microcirculation·2018
Same author

Identification of Factors Influencing Cumulative Long-Term Radiation Exposure in Patients Undergoing EVAR.

International journal of vascular medicine·2017
Same author

Functional Organ Replacement, The New Technology of Tissue Engineering.

Surgical technology international·2017
Same author

Allogeneic Blood Product Usage in Coronary Artery Bypass Grafting (CABG) with minimalized Extracorporeal Circulation System (MECC) Versus Standard On-Pump Coronary Artery Bypass Grafting.

The open cardiovascular medicine journal·2016
Same author

Daptomycin for the treatment of major gram-positive infections after cardiac surgery.

Journal of cardiothoracic surgery·2016

Tissue engineering addresses organ shortages by creating functional tissues using cells and biodegradable scaffolds. This innovative field shows promise with ongoing clinical trials for skin and cartilage regeneration.

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Cell Biology

Background:

  • Significant organ shortage and limitations of current prosthetic materials drive the need for tissue engineering solutions.
  • Tissue engineering aims to develop functional, self-sustaining tissues for repair and replacement.
  • This multidisciplinary field encompasses various organs and tissues, focusing on restoration of biological function.

Purpose of the Study:

  • To provide an overview of the emerging field of tissue engineering.
  • To discuss current approaches, including cell-based therapies and scaffold utilization.
  • To highlight the progress and future prospects of tissue engineering research.

Main Methods:

  • Utilizing biodegradable or resorbable scaffolds shaped to mimic native tissue architecture.

Related Experiment Videos

  • Seeding scaffolds with cells, sourced from biopsies or stem cells.
  • Observing cell proliferation, organization, and extracellular matrix production on scaffolds.

    • Main Results:

    • Scaffolds support cell growth, organization, and matrix deposition, leading to new tissue formation.
    • The initial scaffold material is gradually degraded or resorbed as new tissue develops.
    • Early clinical trials for engineered skin and cartilage substitutes are underway.

    Conclusions:

    • Tissue engineering offers a promising solution to organ and tissue replacement challenges.
    • The combination of cells and advanced scaffolds is a key strategy in regenerative medicine.
    • Ongoing research and clinical trials indicate a positive future for tissue-engineered products.